Pfizer Buys Rights to PD-1 & VEGF Inhibitor From China Biotech

• click to rate

  Posted by Two Blokes May 20, 2025 - Filed in Stock - 5 views
  
  PFE in-licenses global rights, ex-China, to SSGJ-707, from Chinese biotech, 3SBio for an upfront payment of $1.25 billion.